Literature DB >> 19473420

Complications of hysterectomy in women with von Willebrand disease.

A H James1, E R Myers, C Cook, R Pietrobon.   

Abstract

Case reports and small case series suggest that women with von Willebrand disease (VWD) are at a very high risk of bleeding complications with hysterectomy. As the procedure may be beneficial to women who suffer from heavy menstrual bleeding and have completed childbearing, an understanding of the true risks involved is essential for appropriate decision making. To estimate the incidence of bleeding and other complications in women with VWD who undergo hysterectomy. The United States Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality for the years 1988-2004 was queried for all hysterectomies for non-malignant conditions. Data were analysed based on the NIS sampling design. Bivariate analyses were used to examine the differences between women with and without VWD. Multivariate analysis was used to adjust for potential confounders among women who underwent hysterectomy for heavy menstrual bleeding. 545 of the 1 358 133 hysterectomies were to women with VWD. Women with VWD were significantly more likely to experience intraoperative and postoperative bleeding (2.75% vs. 0.89%, P < 0.001) and require transfusion (7.34% vs. 2.13%, P < 0.001) than women without VWD. One woman with VWD died. While the risk of bleeding complications from hysterectomy in women with VWD is smaller than previously reported, women with VWD did experience significantly more bleeding complications than women without VWD. Nonetheless, for women who have completed childbearing, the risks of hysterectomy may be acceptable.

Entities:  

Mesh:

Year:  2009        PMID: 19473420      PMCID: PMC3740955          DOI: 10.1111/j.1365-2516.2009.02022.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  20 in total

1.  Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease.

Authors:  A I Woods; S S Meschengieser; A N Blanco; M J Salviú; C E Farías; A C Kempfer; M A Lazzari
Journal:  Haematologica       Date:  2001-04       Impact factor: 9.941

Review 2.  Impact, diagnosis and treatment of von Willebrand disease.

Authors:  J E Sadler; P M Mannucci; E Berntorp; N Bochkov; V Boulyjenkov; D Ginsburg; D Meyer; I Peake; F Rodeghiero; A Srivastava
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

3.  von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia.

Authors:  A Dilley; C Drews; C Miller; C Lally; H Austin; D Ramaswamy; D Lurye; B Evatt
Journal:  Obstet Gynecol       Date:  2001-04       Impact factor: 7.661

4.  Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study.

Authors:  A Kirtava; C Drews; C Lally; A Dilley; B Evatt
Journal:  Haemophilia       Date:  2003-05       Impact factor: 4.287

5.  von Willebrand disease and bleeding in women.

Authors:  M V Ragni; F A Bontempo; A C Hassett
Journal:  Haemophilia       Date:  1999-09       Impact factor: 4.287

6.  Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease.

Authors:  A H James; M G Jamison
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

7.  Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey.

Authors:  P A Kouides; P D Phatak; P Burkart; C Braggins; C Cox; Z Bernstein; L Belling; P Holmberg; W MacLaughlin; F Howard
Journal:  Haemophilia       Date:  2000-11       Impact factor: 4.287

8.  Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women.

Authors:  C H Miller; A Dilley; L Richardson; W C Hooper; B L Evatt
Journal:  Am J Hematol       Date:  2001-06       Impact factor: 10.047

9.  Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease.

Authors:  M Lak; F Peyvandi; P M Mannucci
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

10.  Platelet functional defects in women with unexplained menorrhagia.

Authors:  C S Philipp; A Dilley; C H Miller; B Evatt; A Baranwal; R Schwartz; G Bachmann; P Saidi
Journal:  J Thromb Haemost       Date:  2003-03       Impact factor: 5.824

View more
  4 in total

1.  Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.

Authors:  V R Byams; P A Kouides; R Kulkarni; J R Baker; D L Brown; J C Gill; A M Grant; A H James; B A Konkle; J Maahs; M M Dumas; S McAlister; D Nance; D Nugent; C S Philipp; J M Soucie; E Stang
Journal:  Haemophilia       Date:  2011-07       Impact factor: 4.287

Review 2.  Heavy menstrual bleeding: work-up and management.

Authors:  Andra H James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists.

Authors:  Vanessa R Byams; Britta L Anderson; Althea M Grant; Hani Atrash; Jay Schulkin
Journal:  Am J Obstet Gynecol       Date:  2012-07-16       Impact factor: 8.661

4.  The Cost of Von Willebrand Disease in Europe: The CVESS Study.

Authors:  George Morgan; Sarah Brighton; Mike Laffan; Jenny Goudemand; Bethany Franks; Alan Finnegan
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.